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Abstract

The objective of this prospective survey series was to evaluate knowledge and concerns related to the COVID-19
pandemic among individuals with one or more chronic conditions, including cardiometabolic, autoimmune, respiratory
and cancer diagnoses. Two surveys were distributed consisting of up to 55 items (March; n=1069) and up to 71 items
(April, n=1126), with 24 items repeated from the first survey. Questions focused on healthcare access, barriers and
concerns related to the COVID-19 virus. Descriptive analysis evaluated central tendencies, spread, and frequencies of
the demographic data, disease states, and survey results within and between the two survey timepoints. Results from 416
individuals (38.9%) on survey 1 and 425 (37.7%) on survey 2 were analyzed. Participants were predominantly female
(85%) and white (67%) with 7% residing in rural areas and 69% employed. Respondents reported an average of 2
chronic conditions and 62% would be classified as “at risk” for COVID-19 complications by the CDC. Only 20%
reported a conversation about COVID-19 with a healthcare provider, 9% reported anxiety, 35% indicated loneliness.
Level of concern about COVID-19 contracting the disease, cost of treatment/complications, medical access, and
process of being treated was associated with increased anxiety (p<0.001) and wearing a facemask (p=0.01). Analysis
suggests that analyzing concern and its association with health behaviors and anxiety should be a priority for innovative
solutions. Insights into how the COVID-19 pandemic is impacting individuals with chronic conditions are imperative to
inform tailored interventions to support individuals at higher risk of serious complications and death.
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Background
Since the World Health Organization declared 2019 novel
coronavirus disease (COVID-19) a pandemic on March
11, 2020, rapidly emerging data have provided insight into
which populations are at greatest risk for contracting and
experiencing serious complications, including death, from
the virus. As of July 23, 2020, there have been 15,012,731
confirmed cases and 619,150 deaths worldwide,1 of which
the largest percentage have occurred in the United States
with 3,952,273 cases and 142,755 deaths,2 respectively.
From early data emerging from the first COVID-19
epicenter in Wuhan, China,3 to current data in the US,4
individuals with pre-existing chronic conditions are among
the highest risk for morbidity and mortality. A systematic
review5 of hospitalized individuals with COVID-19
identified hypertension, cardiovascular disease, diabetes
mellitus, chronic obstructive pulmonary disease, chronic
kidney disease, and cancer as the most frequently observed
underlying conditions worldwide. The Centers for Disease

Control and Prevention6 (CDC) has also identified
immunocompromise, obesity, asthma and lung disease
among the category of individuals at highest risk for severe
illness. The CDC reports that individuals with underlying
cardiovascular, metabolic and respiratory conditions are six
times more likely to be hospitalized and twelve times more
likely to die from COVID-19 than individuals with no
reported chronic conditions.7
While the potential physical and psychological impact 8 of
the pandemic for individuals with chronic conditions is
beginning to be documented, related both to quarantine9
and to uncertainty and anxiety related to elevated risk for
complications, an understanding of how individuals with
chronic conditions are impacted is still evolving. In
addition to concerns about complications of COVID-19,
modified access to in-person healthcare due to the need
for social distancing to reduce viral spread may result in
reduced or delayed access to care for new or underlying
conditions, further compounding the health implications

Patient Experience Journal, Volume 7, Issue 2 – Special Issue: Sustaining a Focus on Human Experience in the Face of COVID-19
© The Author(s), 2020. Published in association with The Beryl Institute
Downloaded from www.pxjournal.org

39

Insights from individuals with chronic conditions during COVID-19, Burton et al.

for this population. Understanding the experience of these
individuals is pivotal to identify if and how COVID-19 is
impacting access to and engagement with healthcare
systems, as well as individual health behaviors.
Here we present the results specific to health care access,
utilization and concerns from prospective survey data
collection at two timepoints, one in March 2020 and one
in April 2020, from individuals with one or more chronic
conditions. Individuals were recruited from a population
who had previously participated in a digital health
coaching program for chronic conditions. The survey used
both unique and repeated items across the two surveys to
gain insight into how COVID-19 is impacting health
decisions and care access during this unprecedented
pandemic.

Aims
The aim of this descriptive survey study was to evaluate
the experience of individuals with pre-existing chronic
conditions as it relates to health behaviors, concerns, and
healthcare access in the context of COVID-19. In
addition, we sought to describe associations between CDC
classification of high and standard risk for COVID-19
complications, demographic characteristics, and health
behaviors, concerns and access.

Sample & Setting
The sample of survey participants was selected from a
patient insights panel associated with a digital health
coaching program for individuals with one or more diverse
chronic conditions aligned to 4 main categories:
cardiometabolic, respiratory, autoimmune and cancer. The
panel consists of over 1000 individuals who, after
completing the health coaching program, agree to provide
patient insights on a variety of monthly health related
surveys.

Methods
We conducted an exploratory, descriptive survey study
with select repeated measures. Two survey instruments
were developed to examine patient perceptions of the
COVID-19 virus and its impact on their daily lives, health
behaviors and healthcare access. Each survey consisted of
internally developed topical questions related to
knowledge, attitudes, behaviors and access, 3 demographic
questions, and 7 items from validated measures evaluating
anxiety, depression and loneliness. Additional
demographic data, specifically, gender, age, race and
geographic location, is derived from the participant profile
in the patient insights database. This data is collected upon
enrollment into the patient insights panel and is used for
analysis consistent with the terms of agreement for
participation in the panel.
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Validated measures included the Patient Health
Questionnaire-4 (PHQ-4), a validated 4-item questionnaire
consisting of a 2-item depression scale (PHQ-2) and the 2item Generalized Anxiety Disorder (GAD-2) scale, each
scored using a 4- point Likert-type response scale, ranging
from “not at all” to “nearly every day;”10 and the ThreeItem Loneliness Scale,11 an ultra-brief scale designed to
measure loneliness adapted from the UCLA-R Loneliness
Scale.12
Survey Instrument 1 (Survey 1) was comprised of up to 55
items (3 demographic, 45 internally developed, 7
validated), and Survey Instrument 2 (Survey 2) was
comprised of up to 71 items (3 demographic, 61 internally
developed, 7 validated), of which 24 items were repeated
between the two surveys. Both surveys contained
internally developed items that involved survey logic such
that participants may or may not be prompted with
additional items based on their responses.
Internally developed items on Survey 1 focused on
knowledge of COVID-19, including sources of
information and understanding of precautions, as well as
their employment accommodations during COVID19. Internally developed items on Survey 2 focused on the
effects of pandemic on the management of chronic
conditions, including the use of telehealth services, testing,
comfort leaving home and participating in public
gatherings. Due to the rapidly evolving context of
COVID-19, the internally developed survey items were
not validated prior to administration and items differed
between the two surveys based on evolving understanding
of the virus and its potential impact. Survey questions were
aligned to three topical areas: 1) influence of COVID-19
on healthcare access, concerns and behaviors,
2) influence of COVID-19 on work-life conditions and 3)
perceptions related to reliability of information sources.
This paper focuses specifically on and presents data from
items related to healthcare access, concerns and behaviors,
for which there were 16 specific items on Survey 1 (4
unique and 12 repeated) and 29 specific items on Survey 2
(17 unique and 12 repeated).
The two surveys were distributed via email invitation to
the patient insights panel. Survey 1 was distributed to
1,069 panel members in March 2020 and was open for
responses for 6 days, and Survey 2 was distributed to 1,126
panel members in April 2020 and was open for responses
for 7 days. Individuals had the option to complete one or
both surveys and were remunerated $10 USD for
completing Survey 1 and $5 USD for Survey 2.

Data Analysis
Descriptive statistics were used to describe the
demographics of the sample and the survey score
distribution at both time points. For this analysis,
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participants were classified as high or standard risk based
on the CDC guidelines in Table 1. Individuals classified as
high-risk were compared to the remaining sample across
the ordinal and nominal survey questions. Ordinal survey
questions included questions pertaining to the level of
concern for COVID-19 infections and the
financial/economic consequences of precautionary
measures, as well as the items related to anxiety,
depression and loneliness. The appropriate bivariate test
was used to detect significant differences between the two
survey time points for the repeated measure items, (Table
5). For this paper, only items specific to healthcare access,
concerns and behaviors are presented.
Factor analysis was conducted to create a composite
concern variable constructed from the following metrics:
contracting the disease, cost of treatment/complications,
medical access and process of being treated. All four items
were scored on the same 5-point Likert scale from 1
(extremely concerned) to 5 (not concerned at all). All
constructs were reverse coded prior to the factor analysis
to simplify interpretations of subsequent regression using
the concern composite score. Prior to performing the
factor analysis, the dataset was assessed for the

appropriateness for factor analysis by determining the
sampling adequacy and sphericity. There was an
appropriate proportion of common variance indicating
that the latent constructs may be used to explain the
grouping of individual items; therefore, the sample was
adequate for factor analysis (KMO=0.79).14 The
correlation between items were verified by Bartlett's test of
sphericity, which indicated that the variables were
intercorrelated and suited for latent structure identification
(χ2=457.166, df=6, p<0.001).
An unrotated exploratory factor analysis was conducted
and resulted in three identified factors, with only the first
factor having an eigenvalue of one or greater (1.80). The
retained factors accounted for 82.94% of the variation. All
4 items yielded acceptable factor loadings (λ>0.4),15
resulting in contraction concerns (λ=0.6530), cost of
treatment concerns (0.6503), medical access concerns
(λ=0.7095) and testing procedure concerns (λ=0.6675)
loading on to factor one. Factor 1 showed sufficient
internal consistency with Cronbach’s alpha values of
0.7847.16 The latent construct for concern, Factor 1,
obtained from the exploratory factor analysis was validated
using confirmatory factor analysis (CFA), with maximum

Table 1. Centers for Disease Control and Prevention (CDC)13 Identified Risk Factors for Severe Illness due to
COVID-19
Definitive Increased Risk

Possible Increased Risk

Chronic Kidney Disease (CKD

Asthma (moderate-to-severe)

Chronic obstructive pulmonary disease (COPD)

Cerebrovascular Disease

Immunocompromised from solid organ transplant

Cystic Fibrosis

Obesity (BMI 30 or above)

Hypertension or high blood pressure

Serious heart conditions, including heart failure, coronary
artery disease or cardiomyopathies

Immunocompromise (including blood or bone marrow
transplant, immune deficiencies, HIV, use of immune
weakening medications)

Sickly Cell Disease

Neurologic conditions, including dementia

Type 2 diabetes mellitus

Liver disease
Pregnancy
Pulmonary Fibrosis
Smoking
Thalassemia
Type 1 diabetes mellitus
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likelihood estimation. The CFA model for concern
showed an appropriate goodness of fit (χ2=460.6,
p<0.001), with root mean square error of approximation
(RMSEA) of 0.041, comparative fit index (CFI) of 0.997,
Tucker–Lewis index (TLI) of 0.991.
A composite concern score was created from averaging a
participant’s concern level with the four concern items that
were validated in the CFA: contracting COVID-19, cost of
treatment, medical access and testing procedure. To
analyze the relationship between concern and anxiety level,
an ordinary least squared regression was conducted. This
regression included risk classification and whether a
participant felt the COVID-19 pandemic was making it
more difficult to manage health conditions, and controlled
for demographic differences (age, gender, education,
rurality and minority status). Independent logistic
regressions were used to evaluate the effect of concern
level on the wearing a facemask and self-quarantining,
both of which were binary variables. The health behaviors
logistic regressions controlled for the same covariates that
were included in the ordinary least squared regression. All
calculations were completed at the significance level α=.05
and using STATA v16.17

Results
The survey was completed by 416 participants (response
rate 38.9%) at time point 1 and 425 participants (37.7%) at
time point 2. A total of 499 unique individuals participated
in the surveys, with 342 (69%) responding at both
timepoints. Demographics for participants are presented in
Table 2. Survey participants were predominantly female
(85% in both surveys) and white (66% in Survey 1 and
68% in Survey 2), residing within the Southeast (59%
Survey 1 and 60% Survey 2), and currently employed (67%
in Survey 1 and 69% in Survey 2). Respondents reported
an average of 2 chronic conditions and 62% would be
classified as “high risk” for COVID-19 related
complications by the CDC (Table 3). Responses for single
survey items are presented in Table 4 (See Appendix) and
those related to health and concerns are summarized
below.
Survey 1. Specific to this survey were questions related to
participants’ knowledge of COVID-19. The primary
sources of information about preparing for or preventing
the spread of COVID-19 reported by participants were the
CDC or World Health Organization (WHO) (67.2%),
statements from government officials (64.4%), and news
channels (47.8%). Only 18.6% (n=67) of all participant,
and 20.7% (n=46) of high-risk participants reported
having a conversation with their doctor or other healthcare
provider about COVID-19. More than half of all
participants (53.6%) responded they would receive a
vaccination for COVID-19 if one were available, with
39.7% unsure and 6.7% responding they would not. Of
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those at high-risk, 56.3% (n=125) responded they would
receive a vaccine, 37.8% were unsure and 5.9% would
not.

Table 2. Demographics * Information pulled from
data previously in Pack Health’s database
Survey 1
(n=416)

Survey 2
(n=425)

Both
(n=342)

n

n

n

(%)

(%)

(%)

Gender*
Female

352

(85%) 359 (85%) 293 (86%)

Male

51

(12%) 59 (14%) 43 (13%)

Unknown

13

(3%)

18-44

121

(30%) 128 (30%) 101 (29%)

45-64

233

(56%) 239 (56%) 190 (56%)

65+

48

(11%) 50 (12%) 44 (12%)

Unknown

14

(3%)

White

276

(66%) 287 (68%) 232 (68%)

Black

87

(21%) 95 (22%) 72 (21%)

7

(1%)

6

(2%)

Age ranges*

8

(2%)

7

(2%)

Race*

Asian

7

(2%)

5

(1%)

4

Other

46

(11%) 38

(9%)

34 (10%)

(1%)

Employed

278

(67%) 292 (69%) 230 (67%)

Not employed

138

(33%) 133 (31%) 112 (33%)

Employment
Status

Conditions

N=392

N=394

N=320

Autoimmune

134

(34%) 134 (34%) 116 (36%)

Cancer

58

(15%) 61

Cardiometabolic

269

(69%) 273 (69%) 226 (71%)

Respiratory

88

(22%) 93 (24%) 79 (25%)

Other

260

(22%) 262 (67%) 214 (67%)

Midwest

55

(13%) 56 (13%) 46 (14%)

Northeast

54

(13%) 56 (13%) 45 (13%)

Southeast

244

(59%) 253 (60%) 203 (59%)

Southwest

19

(5%)

23

(5%)

16 (5%)

West

37

(9%)

35

(8%)

31 (9%)

Unknown

7

(2%)

2

(1%)

1

16%) 49 (15%)

Region*

(0%)
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Table 3. Participant Risk for Severe Illness due to COVID-19
Survey 1
(n=416)

Survey 2 (n=425) Both (n=342)

n

(%)

n

(%)

n

(%)

291

(70%)

288

(68%)

239

(70%)

204

(49%)

214

(50%)

177

(52%)

Respiratory Condition 101

(24%)

105

(24%)

91

(26%)

Diabetes

97

(23%)

95

(22%)

85

(25%)

Cancer

58

(14%)

61

(14%)

49

(14%)

BMI>40

67

(16%)

66

(19%)

60

(18%)

Age >65

48

(12%)

50

(12%)

44

(13%)

125

(30%)

136

(32%)

102

(30%)

0

125

(30%)

136

(32%)

102

(30%)

1

139

(33%)

133

(31%)

107

(31%)

2

96

(23%)

93

(22%)

78

(23%)

3

40

(9%)

44

(10%)

38

(11%)

4 or more

16

(4%)

19

(5%)

17

(5%)

High Risk
Heart disease

Low Risk
Number of Risk Factors

concerned about the risk of COVID-19 infection for
themselves (p = 0.002) but equally concerned about
family or friends contracting COVID-19, when compared
with the participants with standard risk.
Survey 2. Survey 2 focused on how COVID-19 is
impacting management of participants’ pre-existing
conditions and access to healthcare. Over three fourths
(77.4%) of participants reported needing to access
healthcare treatment since the pandemic started, of which
approximately half (49.5%) had difficulty accessing
treatment. The top barriers to accessing care included
appointments being canceled or rescheduled (61.3%),
healthcare providers not offering elective procedures or
new treatments (13.5%) and avoiding healthcare settings
due to fear of contracting the virus (13.5%). The COVID19 pandemic was reported as making it more difficult to
manage their chronic condition by 27.4% of participants,
most often due to stress (25.9%), the inability to attend
appointments (25.9%), and disruptions to their daily
routine (18.5%). Accessing medications and medical
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supplies was reported as difficult by 13.9% of
participants. About three fourths (74.6%) of participants
responded that their healthcare provider offered telehealth
services. Of those, almost half (40.7%) had already used
their providers’ telehealth services during the pandemic
and the majority (86.8%) reported being pleased with their
experience. Only 12.7% of participants with access to
telehealth services that have either already used them or
plan to use them during the pandemic say they likely will
not continue using telehealth after the pandemic.
Repeated Measures. Results from the 12-items that were
repeated between the 2 surveys specific to healthcare
barriers, access and concerns are presented for all
participants, as well as by high or standard risk in Table 5
(See Appendix). Of note, concern about getting infected
increased while concerns about finances and job loss
decreased over time. There was a 34.5% increase in
individuals who reported being concerned about
contracting COVID-19 from timepoint 1 to timepoint 2
(p<0.001), with 18.7% of respondents reporting a
decreased concern and 46.8% remaining at the same
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Table 6. Relationship Between Concern and Anxiety Based on Demographic Variables
Anxiety

Β

p

Concern

0.676

<0.001

Pandemic making it more difficult (reference group = not)

1.116

<0.001

CDC High Risk (reference group = standard risk)

0.262

0.221

Age

-0.018

0.028

Gender (reference group = male)

0.036

0.895

Rural (reference group = urban)

-0.086

0.754

Non-white (reference group = white)

-0.580

0.006

Technical or trade school

-0.172

0.763

Some college

-0.154

0.699

Associates degree

-0.292

0.481

Bachelor's degree

0.059

0.874

Postgraduate degree

-0.063

0.868

Education (reference group = High School/GED)

concern level. Similarly, there was a 33.6% increase in
concern about a family member or friend contracting
COVID-19, while 22.5% reported decreased concern and
43.9% remained the same. Financial concerns also
decreased over time with 40% of the population reporting
decreased concern and 21% increased concern. A great
number of individuals reported reduced financial concerns
related to medical care and buying daily items. The number
of individuals who reported having no concerns about
access to care increased from Survey 1 (6.4%) to Survey 2
(13.2%), suggesting changes in this area from the start of
the pandemic. Related to mental health, individuals
considered standard risk had a higher mean anxiety score
at timepoint 1 than those in the high-risk group, however
there was no significant difference between the anxiety
distributions at the two time points. Depression outcomes
suggested no significant difference between high and
standard risk groups nor any significant change between
survey timepoints.
Concern Composite. Results related to the relationship
between the concern composite and anxiety by
demographic variables is presented in Table 6. For every 1
unit increase in concern, anxiety increase by .676 points,
on average. Results indicate a statistically significant
relationship between concern and anxiety (p<0.001) based
on age (p=0.028), race (p=0.006), and the perception that
the pandemic is making it harder to manage the
individual’s health condition (p<0.001). For every year
increase in age, anxiety levels decrease by 0.018.
Participants identifying as non-white were less anxious
compared to those who identified as white. Participants
who reported the pandemic is making it more difficult to
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manage their health condition were more anxious
compared to those who felt the pandemic was not making
that management more difficult.
Similarly, the concern composite was compared with selfreported health behaviors across demographic and other
variables (Table 7). Results indicate a statistically
significant relationship between concern and wearing a
facemask based on age (p=0.01) and between concern and
self-quarantining by rurality (p=0.02). The level of concern
is a significant predictor of wearing a face mask but not of
self-quarantining. As the level of concern increases, the
odds of wearing a face mask increases by 57% (OR=1.57,
p=0.003).

Discussion
Survey findings provide insights into the knowledge and
attitudes of individuals with chronic conditions in the
context of COVID-19, as well as how the pandemic has
impacted their access to healthcare. Because of the
increased risk of serious complications, morbidity, and
mortality associated with COVID-19 there is a need to
both protect individuals with chronic conditions from
exposure to COVID-19 while simultaneously ensuring
their healthcare needs are met.
Knowledge, attitudes and behaviors related to
COVID-19. Results suggest that individuals obtain
information about the spread and prevention of COVID19 from diverse sources. While the majority of participants
reported seeking information from the CDC, WHO and
government officials, the third most reported source was

Patient Experience Journal, Volume 7, Issue 2 – 2020
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Table 7. Relationship Between Concern and Health Behaviors Based on Demographic Variables
Wearing Facemask
Odds Ratio

Self-Quarantining
p

Odds Ratio

p

Concern

1.57

0.003

1.22

0.447

Pandemic making it more difficult
(reference group = not)
CDC High Risk
(reference group = standard risk)
Age

1.35

0.379

6.16

0.091

1.46

0.47

0.84

0.789

1.01

0.01

1.02

0.485

Gender
(reference group = male)
Rural
(reference group = urban)
Minority (reference group = white)

1.54

0.61

3.01

0.07

0.47

0.19

0.19

0.024

0.87

0.28

Education
(reference group = High School/GED)
Technical or trade school

0.33

0.164

0.32

0.463

Some college

1.88

0.311

0.58

0.649

Associate degree

1.39

0.612

0.89

0.93

Bachelor's degree

1.24

0.702

1.46

0.756

Postgraduate degree

1.34

0.61

0.97

0.978

news outlets. Accurate knowledge of the virus, its causes
and potential for spread are important, as a survey study in
China18 suggests knowledge is correlated with adoption of
prevention behaviors that may reduce transmission of the
virus. Though these surveys were conducted earlier in the
onset of COVID-19 in the US, the low frequency of
reported conversations with a healthcare provider about
COVID-19, particularly among individuals at highest risk,
suggests the need to implement established evidence-based
education about the virus and its implications for
individuals at standard and high-risk or to develop
materials that address the needs of populations with
unique health conditions or social determinants of health
that can impact exposure, infection and complications
from COVID-19.
Access to healthcare in the context of COVID19. Reports of inability to access or delayed access to care
are consistent with recommendations from professional
organizations19 suggesting how certain tests, procedures
and treatments may be spaced out, structured or delayed
to support social distancing and reduce transmission of the
virus. While these efforts are important measures, the
reality of newly diagnosed and pre-existing conditions
requires that certain care may not be able to be delayed or
that delays may contribute to exacerbations in symptoms,
delayed diagnosis and treatment,20 and potentially poorer
health outcomes. Recommendations for the engagement
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of solutions, most notably telehealth,21 are actively being
explored and operationalized to ensure individuals are able
to engage with healthcare providers in the safety of their
own homes. This is true for both mental22 and physical
health needs, both of which have the capacity to be
exacerbated by COVID-19 and resulting social
isolation. Further, such interventions offer opportunities
for leveraging evolving technology to both address
emergent healthcare needs during COVID-19, as well as to
optimize healthcare access and delivery beyond the
pandemic.23,24
Anxiety, depression and loneliness in the context of
COVID-19. Reviews of existing literature25 suggest that
mental health concerns including depression and anxiety
may be associated with the COVID-19 pandemic. Further,
studies suggest social isolation is associated with increased
risk for cardiovascular death,26 emphasizing the need for
interventions that target reducing social isolation for
individuals during COVID-19 and beyond. New
instruments27 are being designed and validated to assess
for anxiety specific to COVID-19, which may serve to
screen individuals with pre-existing and newly emerging
anxiety to identify opportunities for interventions.
Appreciating how anxiety, depression and loneliness may
uniquely affect individuals with chronic conditions, who
may experience higher levels of anxiety and depression
during COVID-19 and who may have increased isolation
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due to fear of contracting the virus and risk for more
severe complications, is important to ensuring that not
only physical but also existing and emerging mental health
needs are addressed for this vulnerable population.
The role of concern in health outcomes. The design of
a concern composite, while preliminary, provides unique
insights into how individuals’ level of concerns about
aspects of their health and its management during
COVID-19 may influence both behaviors and outcomes,
including anxiety. The concern composite was derived
from alignment of scores on items related to concerns
across 4 items: contracting COVID-19, cost of treatment
for COVID-19, access to healthcare due to COVID-19
and COVID-19 testing procedures. Because existing
models28 promote the relationship between concern about
or perception of risk for adverse health events and
motivation for change in health behavior, understanding
how concerns about COVID-19 may influence healthcare
access and behaviors is pivotal to developing thoughtful
and targeted interventions. Here we observed few
relationships between level of concern and health
behaviors, with concern associated only with mask wearing
but not with self-quarantine. While this could be reflective
of the relatively early timepoints at which the survey was
administered, it could also be the phenomenon of
quarantine fatigue, the process by which the practice of
self-isolation leads to less sensitivity to the danger of
COVID-19 and resulting leniency with respect to
protective behaviors (e.g. mask wearing, staying home).29
A study at The University of Maryland suggests less than
30% of individuals in any state are staying home.30 Given
this data, it is important to consider that concern about
contracting the virus may not be sufficient to overcome
the want or need to travel outside one’s home, due to
circumstances ranging from personal preference to inperson work requirements to the need for medical care. In
the event staying at home or effective social distancing
cannot be adhered to, ensuring the adoption of healthy
practices including mask wearing and frequent hand
washing are important to reduce viral spread. This is of
particular importance as studies increasingly demonstrate
the potential for asymptomatic spread.31

Study Limitations
This study has several limitations. One limitation was the
use of primarily non-validated survey instruments, with the
exception of the PHQ-4 and the Three Item Loneliness
Scale. Further, the use of unique questions on each survey
reflects the development of the surveys as the COVID-19
pandemic and its implications evolved. The exploratory
descriptive nature of this data is a limitation but also a
reflection of the rapidly evolving circumstances
surrounding the virus. Further, the participants were
predominantly white, and more than half reside in the
southeast US. Given regional variation in responses to and
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restrictions related to COVID-19, the responses may
reflect this variability of regional practices. Ultimately
COVID-19 is an intensely personal human experience in
the context of global pandemic, for which unique health
needs, social determinants of health, and internalization of
the pandemic experience can result in vastly different
experiences. Therefore, the insights derived here must be
balanced with patient-centered approaches to care for this
vulnerable population.
Despite these limitations the study findings provide
important insights into the experience of individuals with
chronic conditions who are most vulnerable to
complications of COVID-19, if infected. The data provide
real-world insights into how individuals with chronic
conditions are experiencing healthcare access, concerns
and barriers during this unprecedented pandemic. Survey
questions can be further adapted and implemented in the
current context as cases rapidly escalate in the US or may
be used as a repeated measures approach to capturing how
access, barriers and concerns evolve in the context of
endemic COVID-19.

Conclusion
COVID-19 is anticipated to transform the delivery of
healthcare globally and in the US. Capturing insights from
individuals with chronic conditions, who account for the
largest percentage of healthcare utilization in the US and
who are concurrently at highest risk for COVID-19 related
complications, is imperative to understanding how to
optimize systems with the capacity to address care needs
both during and beyond a pandemic. This is important to
support the health and physical and mental well-being of
individuals with chronic conditions in a safe manner,
contributing to reduced exposure to and spread of the
virus, as well as to decompress demands on healthcare
systems, many of which are approaching capacity
providing COVID-19 related care. This survey study
provides insights into the experience of individuals with
chronic conditions, as it relates to their healthcare
behaviors, concerns and access during the COVID-19
pandemic. Specifically, it contributes to the literature by
elucidating concerns about self or family members
contracting COVID-19, barriers to accessing healthcare
for underlying chronic conditions, prevalence of anxiety,
depression and loneliness and how these data may differ
over time and by risk for COVID-19 complications per
CDC guidelines. Those at higher risk may have increased
concern about contracting the virus which may in turn
affect their comfort in seeking healthcare outside their
homes. In addition, outcomes suggest that mental health,
specifically loneliness which has been correlated with
poorer health outcomes, should be a priority for process
improvement and research across diverse healthcare
settings. The need for innovative, yet scalable solutions to
support healthcare needs within home and community-
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based settings, including digital health solutions, is pivotal
to our capacity to rapidly respond to COVID-19 as it
unfolds and to proactively prepare for future shifts in both
pandemic and non-pandemic driven healthcare utilization.
Insights into how the COVID-19 pandemic is impacting
individuals with chronic conditions are imperative to
inform tailored interventions to support populations at
higher risk of serious complications and death. Now is a
pivotal time to leverage the insights, experiences and
voices of individuals must vulnerable to COVID-19 and
most dependent upon healthcare systems and utilization to
create an optimal, patient-centered path forward,
supporting the physical and mental health of individuals
across diverse settings.
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Appendix
Table 4. Results for Single Survey Items Specific to Health Care Access, Behaviors and Concerns
Survey 1 (March 2020)
When did you first hear about COVID-19?
November 2019
42 (10%)
December 2019
89 (21%)
January 2020
140 (34%)
February 2020
101 (24%)
March 2020
44 (2%)
Are there any confirmed cases of COVID-19 in your area?
Yes
335 (81%)
No
58 (14%)
I do not know
23 (5%)
Have you talked with your doctor or other healthcare providers about COVID-19?
Yes
87 (21%)
No
329 (79%)
If a vaccine is developed for COVID-19, will you get it?
Yes
220 (53%)
No
27 (7%)
Maybe
169 (41%)
Survey 2 (April 2020)
Do you know anyone who has been diagnosed with COVID-19?
Yes
159 (37%)
No
266 (63%)
Have you been exposed to COVID-19?
Yes
19 (5%)
No
192 (45%)
I am not sure
214 (50%)
How concerned are you about the process of being tested for COVID-19 (worry about discomfort, cost of testing, etc.)
Extremely concerned
57 (13%)
Very concerned
50 (12%)
Moderately concerned
99 (23%)
Slightly concerned
95 (22%)
Not concerned at all
124 (29%)
Have you been tested?
Yes
295 (69%)
No
130 (31%)
Have you experienced symptoms of COVID-19 but have been unable to get a test?
Yes
16 (4%)
No
395 (96%)
Do you think you would be considered a "high risk" patient if you contracted COVID-19?
Yes
258 (61%)
No
105 (25%)
I don't know
62 (15%)
Yes, my level of activity has increased a lot
34 (8%)
Yes, my level of activity has increased somewhat
75 (18%)
Yes, my level of activity has decreased a lot
157 (37%)
Yes, my level of activity has decreased somewhat
98 (23%)
No, my activity level has stayed the same
61 (14%)
Have you been forced to choose between utilities, food, medicine, etc. because of COVID-19?
Yes
35 (8%)
No
390 (92%)
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Appendix
Table 4. Results for Single Survey Items Specific to Health Care Access, Behaviors and Concerns (cont’d.)
Do you have access to healthy food during this time?
Yes
379 (89%)
No
33 (8%)
Have you had difficulty accessing healthcare treatment you need? (i.e. cancelled doctor appointments, clinics closed,
etc.)
Yes
163 (38%)
No
166 (39%)
I have not yet had to get healthcare treatment since the pandemic started
96 (23%)
Have you had difficulty getting your regular medications or medical supplies such as test strips?
Yes, I had to switch to mail order
11 (3%)
Yes, it takes longer to get my medications/supplies
22 (5%)
Yes, it is more difficult to go to the pharmacy to get my medications/supplies
26 (6%)
No, I have not had any issues getting medications/supplies
298 (70%)
I have not had to order medications since the pandemic started
24 (6%)
I do not take any medications
32 (8%)
Other
12 (3%)
Do you feel the COVID-19 pandemic is making it more difficult to manage your condition?
Yes
108 (27%)
No
286 (73%)
Do you have access to a patient portal that allows you to view your health information and contact your doctor?
Yes, and I use it
291 (69%)
Yes, but I do not use it
87 (21%)
No
25 (6%)
I'm not sure
22 (5%)
Does your healthcare provider offer telehealth services?
Yes
317 (75%)
No
26 (6%)
Unsure
82 (19%)
Do you plan to use telehealth services to communicate with your healthcare provider during this time?
Yes, and I have already used telehealth services
129 (41%)
No
38 (12%)
I don't know how to use telehealth services
4 (1%)
Yes, but I have not yet used telehealth services
146 (46%)
Do you think having access to telehealth services to communicate with your provider will be helpful during this
time?
Yes
23 (89%)
No
3 (12%)
How would you rate your experience with telemedicine?
Extremely pleased
74 (57%)
Somewhat pleased
38 (30%)
Neither pleased nor displeased
9 (7%)
Somewhat displeased
8 (6%)
Extremely displeased
0 (0%)
Do you think you will continue to use telemedicine outside of the pandemic?
Definitely yes
83 (30%)
Probably yes
73 (27%)
Might or might not
84 (31%)
Probably not
30 (11%)
Definitely not
5 (2%)
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Appendix
Table 5. Results for Repeated Measure Items
Questions
How concerned are you about contracting COVID-19 yourself?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all
How concerned are you about friends and family contracting
COVID-19?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all
How concerned are you about losing work because of COVID-19?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all
How concerned are you about financial fallout due to COVID-19?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all
How concerned are you about personal financial issues due to
COVID-19 (cost of treatment, complications, etc.)?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all
How concerned are you about not being able to get everyday
necessities (e.g. food, medicine)?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all

How concerned are you about not being able to access needed
medical care?
Extremely concerned
Very concerned
Moderately concerned
Slightly concerned
Not concerned at all
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Survey 1
Responses
n (%)
x̄ (SD)
416
3.35 (1.15)
87 (21%)
91 (22%)
144 (35%)
70 (17%)
24 (6%)
416
3.75 (1.10)

Survey 2
Responses
n
x̄ (SD)
425
3.61 (1.13)
120 (28%)
106 (25%)
126 (30%)
60 (14%)
13 (3%)
425
3.96 (1.02)

125 (30%)
132 (32%)
102 (25%)
42 (10%)
15 (4%)
416
2.51 (1.50)
70 (17%)
44 (11%)
78 (19%)
60 (14%)
164 (39%)
416
3.64
136 (33%)
109 (26%)
87 (21%)
55 (13%)
29 (7%)
416
3.31 (1.34)

155 (37%)
146 (34%)
83 (20%)
33 (8%)
8 (2%)
425
2.45 (1.43)
59 (14%)
45 (11%)
80 (19%)
85 (20%)
156 (37%)
425
3.40 (1.26)
105 (25%)
100 (24%)
118 (28%)
63 (15%)
39 (9%)
425
3.12 (1.31)

110 (26%)
81 (20%)
100 (24%)
78 (19%)
47 (11%)
416
3.39 (1.21)

84 (20%)
83 (20%)
115 (27%)
86 (20%)
57 (13%)
425
3.06 (1.16)

< 0.001

100 (24%)
95 (23%)
114 (27%)
83 (20%)
24 (6%)
416
3.38 (1.27)

60 (14%)
85 (20%)
141 (33%)
102 (24%)
37 (9%)
425

<0.001

102 (25%)
100 (24%)
101 (24%)
78 (19%)
35 (8%)

74 (17%)
96 (23%)
111 (26%)
88 (21%)
56 (13%)

3.1

P
< 0.001

< 0.001

0.42

< 0.001

0.0029
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Appendix
Table 5. Results for Repeated Measure Items (cont’d.)
Is COVID-19 testing available in your area?
Yes
No
I do not know
Yes, but only for people that fit a specific criterion
Do you know where to go to get tested for COVID-19?
Yes
No
What precautions are you taking to prevent disease?
Frequent hand washing
Using hand sanitizer regularly
Avoiding touching others or surfaces
Avoiding touching your face
Wearing facemasks
Frequently cleaning your phone or other regularly touched items
Regularly disinfecting surfaces
Keeping six feet of distance between yourself and others
Practicing social distancing (avoiding public places or groups of people)
Other
I am not taking any precautions to prevent disease
Are you currently employed? / Were you employed in February 2020?
Yes
No
Patient Health Questionnaire (PHQ) 4
Anxiety
Depression
UCLA Loneliness Scale Questions
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416
101 (24%)
19 (5%)
99 (24%)
197 (47%)
416
199 (67%)
99 (33%)
416
402 (97%)
320 (77%)
330 (79%)
337 (81%)
36 (9%)
260 (63%)
299 (72%)
295 (71%)
366 (88%)
20 (5%)
3 (1%)

425
118 (28%)
13 (3%)
39 (9%)
255 (60%)
425
295 (69%)
130 (31%)
425
412 (97%)
335 (79%)
340 (80%)
321 (76%)
315 (74%)
290 (68%)
293 (69%)
395 (93%)
394 (93%)
21 (5%)
2 (1%)

278 (67%)
138 (33%)
416
1.74 (1.75)
1.08
416

292 (69%)
133 (31%)
425
1.79 (1.76)
1.31 (1.51)
425

< 0.001

0.29

0.66
0.30
0.73
0.017
< 0.001
0.0162
0.20
< 0.001
< 0.001
0.83
0.57
0.34

0.5834
0.0027
< 0.001
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